Parkinson's Disease Clinical Trials

Find Parkinson's Disease Clinical Trials Near You

Development of Digital Diagnostic Devices for Parkinson's Disease

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

In this project, ocular motor, pupil and gait data in people with Parkinson's disease (PD) will be collected in order to develop machine learning models for the diagnosis and monitoring of PD. With this, the investigators aim to advance the state of the art in PD diagnosis and monitoring. By integrating the principles of machine learning with high-quality sensor data, more accurate and earlier diagnosis could potentially be achieved. Ocular motor and pupil data will be collected with the standard clinical examination and with neos, a medical device approved for objective ocular motor and pupil measurement. Gait will be collected using an IMU sensor and GaitQ senti, a consumer device that allows for an objective and continuous remote gait monitoring.

Eligibility
Participation Requirements
Sex: All
View:

• Diagnosis of Parkinson's disease or of another parkinsonian syndrome (atypical Parkinson's)

• Refractive error between -6 and +4 diopters, on both eyes

• Informed consent by participant documented per signature

• Able to self-report history of daily gait freezing and/or festination

• Able to walk unsupported or using an aid for at least 5 minutes and if over 69 used to carrying out this level of exercise

Locations
Other Locations
Switzerland
University Hospital of Zurich
RECRUITING
Zurich
Contact Information
Primary
Ana Coito, Ph.D.
ana.coito@machinemd.com
+41 (0)31 589 67 92
Backup
Pia Massatsch, Ph.D.
pia.massatsch@machinemd.com
Time Frame
Start Date: 2024-10-01
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 100
Treatments
people with Parkinson's disease
Atypical parkinsonism
Related Therapeutic Areas
Sponsors
Collaborators: University Hospital, Zürich, gaitQ Limited, University of Exeter, University of Zurich
Leads: machineMD AG

This content was sourced from clinicaltrials.gov